These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 30291583)

  • 1. Effects of Neutralizing Antibody Production on AAV-PHP.B-Mediated Transduction of the Mouse Central Nervous System.
    Shinohara Y; Konno A; Nitta K; Matsuzaki Y; Yasui H; Suwa J; Hiromura K; Hirai H
    Mol Neurobiol; 2019 Jun; 56(6):4203-4214. PubMed ID: 30291583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Widespread transduction of astrocytes and neurons in the mouse central nervous system after systemic delivery of a self-complementary AAV-PHP.B vector.
    Rincon MY; de Vin F; Duqué SI; Fripont S; Castaldo SA; Bouhuijzen-Wenger J; Holt MG
    Gene Ther; 2018 Apr; 25(2):83-92. PubMed ID: 29523880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice.
    Liguore WA; Domire JS; Button D; Wang Y; Dufour BD; Srinivasan S; McBride JL
    Mol Ther; 2019 Nov; 27(11):2018-2037. PubMed ID: 31420242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of neuron-specific promoters in mouse brain transduced by intravenously administered AAV-PHP.eB.
    Radhiyanti PT; Konno A; Matsuzaki Y; Hirai H
    Neurosci Lett; 2021 Jun; 756():135956. PubMed ID: 33989730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous administration of the adeno-associated virus-PHP.B capsid fails to upregulate transduction efficiency in the marmoset brain.
    Matsuzaki Y; Konno A; Mochizuki R; Shinohara Y; Nitta K; Okada Y; Hirai H
    Neurosci Lett; 2018 Feb; 665():182-188. PubMed ID: 29175632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focused ultrasound as a novel strategy for noninvasive gene delivery to retinal Müller glia.
    Touahri Y; Dixit R; Kofoed RH; Miloska K; Park E; Raeisossadati R; Markham-Coultes K; David LA; Rijal H; Zhao J; Lynch M; Hynynen K; Aubert I; Schuurmans C
    Theranostics; 2020; 10(7):2982-2999. PubMed ID: 32194850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Context-Specific Function of the Engineered Peptide Domain of PHP.B.
    Martino RA; Fluck EC; Murphy J; Wang Q; Hoff H; Pumroy RA; Lee CY; Sims JJ; Roy S; Moiseenkova-Bell VY; Wilson JM
    J Virol; 2021 Sep; 95(20):e0116421. PubMed ID: 34346767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intramuscular administration of AAV overcomes pre-existing neutralizing antibodies in rhesus macaques.
    Greig JA; Calcedo R; Grant RL; Peng H; Medina-Jaszek CA; Ahonkhai O; Qin Q; Roy S; Tretiakova AP; Wilson JM
    Vaccine; 2016 Dec; 34(50):6323-6329. PubMed ID: 27817961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular selectivity of AAV serotypes for gene delivery in neurons and astrocytes by neonatal intracerebroventricular injection.
    Hammond SL; Leek AN; Richman EH; Tjalkens RB
    PLoS One; 2017; 12(12):e0188830. PubMed ID: 29244806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E, low-density lipoprotein receptor, and immune cells control blood-brain barrier penetration by AAV-PHP.eB in mice.
    Xie BS; Wang X; Pan YH; Jiang G; Feng JF; Lin Y
    Theranostics; 2021; 11(3):1177-1191. PubMed ID: 33391529
    [No Abstract]   [Full Text] [Related]  

  • 11.
    Batista AR; King OD; Reardon CP; Davis C; Shankaracharya ; Philip V; Gray-Edwards H; Aronin N; Lutz C; Landers J; Sena-Esteves M
    Hum Gene Ther; 2020 Jan; 31(1-2):90-102. PubMed ID: 31696742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody neutralization poses a barrier to intravitreal adeno-associated viral vector gene delivery to non-human primates.
    Kotterman MA; Yin L; Strazzeri JM; Flannery JG; Merigan WH; Schaffer DV
    Gene Ther; 2015 Feb; 22(2):116-26. PubMed ID: 25503696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GABAergic neuron-specific whole-brain transduction by AAV-PHP.B incorporated with a new GAD65 promoter.
    Hoshino C; Konno A; Hosoi N; Kaneko R; Mukai R; Nakai J; Hirai H
    Mol Brain; 2021 Feb; 14(1):33. PubMed ID: 33588899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of Spinocerebellar Ataxia Type 3 Model Mice by Intravenous Injection of AAV-PHP.B Vectors.
    Konno A; Shinohara Y; Hirai H
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective transgene expression in cerebellar Purkinje cells and granule cells using adeno-associated viruses together with specific promoters.
    Kim Y; Kim T; Rhee JK; Lee D; Tanaka-Yamamoto K; Yamamoto Y
    Brain Res; 2015 Sep; 1620():1-16. PubMed ID: 25988836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of adeno-associated virus neutralizing antibody activity for clinical application.
    Wang M; Crosby A; Hastie E; Samulski JJ; McPhee S; Joshua G; Samulski RJ; Li C
    Gene Ther; 2015 Dec; 22(12):984-92. PubMed ID: 26125606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracerebroventricular Administration of AAV9-PHP.B SYN1-EmGFP Induces Widespread Transgene Expression in the Mouse and Monkey Central Nervous System.
    Galvan A; Petkau TL; Hill AM; Korecki AJ; Lu G; Choi D; Rahman K; Simpson EM; Leavitt BR; Smith Y
    Hum Gene Ther; 2021 Jun; 32(11-12):599-615. PubMed ID: 33860682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful AAV8 readministration: Suppression of capsid-specific neutralizing antibodies by a combination treatment of bortezomib and CD20 mAb in a mouse model of Pompe disease.
    Choi SJ; Yi JS; Lim JA; Tedder TF; Koeberl DD; Jeck W; Desai AK; Rosenberg A; Sun B; Kishnani PS
    J Gene Med; 2023 Aug; 25(8):e3509. PubMed ID: 36994804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and Relevance of Pre-Existing Anti-Adeno-Associated Virus Immunity in the Context of Gene Therapy for Crigler-Najjar Syndrome.
    Aronson SJ; Veron P; Collaud F; Hubert A; Delahais V; Honnet G; de Knegt RJ; Junge N; Baumann U; Di Giorgio A; D'Antiga L; Ginocchio VM; Brunetti-Pierri N; Labrune P; Beuers U; Bosma PJ; Mingozzi F
    Hum Gene Ther; 2019 Oct; 30(10):1297-1305. PubMed ID: 31502485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivering genes across the blood-brain barrier: LY6A, a novel cellular receptor for AAV-PHP.B capsids.
    Huang Q; Chan KY; Tobey IG; Chan YA; Poterba T; Boutros CL; Balazs AB; Daneman R; Bloom JM; Seed C; Deverman BE
    PLoS One; 2019; 14(11):e0225206. PubMed ID: 31725765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.